Q3 2020 Sunesis Pharmaceuticals Inc Earnings Call Transcript
Welcome to Sunesis Pharmaceuticals Third Quarter 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to turn the conference over to Par Hyare, Senior Vice President, Commercial. Please go ahead, sir.
Thank you. Welcome, everyone, and thank you for joining us today. With me on the call today are Dayton Misfeldt, Interim CEO; Judy Fox, Chief Scientific Officer, EVP of Research and Development. Dayton will start by reviewing recent corporate events and will provide a brief financial overview of the third quarter of 2020. We will then open the call for questions.
Before we begin, let me remind you that during today's conference call, we will be making forward-looking statements that represent the company's intentions, expectations or beliefs concerning future events. These forward-looking statements are qualified by important factors set forth in today's press release and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |